OXYCODONE
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $18,519 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $18,519 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Randomized, Open-Label, 2-way Crossover Bioequivalence Study of Doxepin Cream, 5 Manufactured by Amneal Pharmaceuticals LLC and Zonalon Doxepin Cream, 5 Marked by Bioglan Phamra Inc. Following a 3-Gram Dose to Healthy Subjects 172005 | Amneal Pharmaceuticals LLC | $18,519 | 0 |
Top Doctors Receiving Payments for OXYCODONE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | — | $18,519 | 1 |
Manufacturing Companies
- Amneal Pharmaceuticals LLC $18,519
Product Information
- Type Drug
- Total Payments $18,519
- Total Doctors 0
- Transactions 1
About OXYCODONE
OXYCODONE is a drug associated with $18,519 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.
Payment data is available from 2018 to 2018. In 2018, $18,519 was paid across 1 transactions to 0 doctors.
The most common payment nature for OXYCODONE is "Unspecified" ($18,519, 100.0% of total).
OXYCODONE is associated with 1 research study, including "Randomized, Open-Label, 2-way Crossover Bioequivalence Study of Doxepin Cream, 5 Manufactured by Amneal Pharmaceuticals LLC and Zonalon Doxepin Cream, 5 Marked by Bioglan Phamra Inc. Following a 3-Gram Dose to Healthy Subjects 172005" ($18,519).